U.S. FDA Approves Two Drugs Of India’s Strides Arcolab
This article was originally published in PharmAsia News
Executive Summary
Strides Arcolab of India has been cleared by the U.S. FDA to market two drugs aimed at improving blood circulation. One is its dexamethasone injection, the other is dexamethasone sodium phosphate. The drugs are to be marketed through a joint venture Strides has with Akom, Akom-Strides. The drugs are aimed at fluid retention and swelling in the brain, plus problems with blood circulation caused by trauma. (Click here for more